← Open Payments lookup

KRISTEN KOLLER: Open Payments

NPI 1508131699 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$434 in 12 payments from 9 companies in 2025. Trend: 2023 $216 · 2024 $830 · 2025 $434

Food & beverage: $434
CompanyPaymentsAmount
Gilead Sciences, Inc.1$127
Boston Scientific Corporation2$76
Lilly USA, LLC2$57
Ipsen Biopharmaceuticals, Inc2$49
ABBVIE INC.1$30
Novo Nordisk Inc1$26
Janssen Biotech, Inc.1$25
Janssen Scientific Affairs, LLC1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$22

Products named: Livdelzi, OverStitch Endoscopic Suturing System, OMVOH, IQIRVO, TREMFYA, SKYRIZI, Wegovy, XIFAXAN.

Industry payments across DC — which companies pay providers there.